Prognosis is good for remote medication monitoring
A medtech company’s special bin for patients who self-inject medications at home is one of a range of ‘digital therapeutics’ that could help improve health outcomes for people with illnesses like cancer and rheumatoid arthritis
In November last year, medtech company HealthBeacon announced it was looking to raise €5 million, to bring its total funding to €8 million. By now, it is €2.5 million into its funding and will launch into another 11 markets by the end of 2018.
These kind of investments are common for companies with the next blockbuster drug or game changing medical device, but HealthBeacon, though only four years old, finds itself in one ...
